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ABSTRACT
Diethylene glycol monoethyl ether (DEGEE) is a promising solvent component in topical cream
formulations due to its superior solubilizing abilities with certain active pharmaceutical
ingredients. One of the goals of this study is to characterize the effects of pH on the physical and
chemical stabilities of topical cream formulations containing particularly high concentrations of
DEGEE by characterizing a full topical pH profile of 3.5 – 9.0. The second goal is to evaluate
the presence, amount, and characteristics of lyotropic liquid crystals (LLCs), molecularly
structured in a lamellar phase, in a model cream emulsion utilizing polarized light microscopy
(PLM). The presence of lamellar structured LLCs has been found to improve the overall
character and stability of cream formulations. In this study, it was found that the oil-in-water
emulsion is physically stable at pH values under the inflection point. Chemical stability was
confirmed by an accelerated temperature condition at 40°C where the pH value was stable
throughout the topical profile. The presence and abundance of lamellar LLCs at the oil-water
interface were found to be more abundant at pH values below the inflection point. The
introduction of thermal studies provided interesting results when lamellar LLCs were heated and
slow cooled to ambient conditions. It is possible a different crystalline structure was produced
upon cooling the sample; however, continued research is needed to definitively determine these
results.

KEYWORDS: oil-in-water, surfactant, crystal, lamellar, polarized, microscopy, birefringence,
lyotropic, hot stage
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CHAPTER I: INTRODUCTION

The stratum corneum (SC) is the top layer of the skin that creates a barrier to protect us
from particles, chemicals, ultraviolet radiation, and other toxins that could enter our bodies and
become systemic.1 Where active pharmaceutical ingredient (API) delivery is concerned,
however, the skin has become another option for delivering APIs. Transdermal delivery has been
found to be a safer and preferred route of delivery, compared to oral and parenteral delivery, for
specific APIs. The barrier of the SC must be manipulated in such a way that targeted molecules
can pass through the skin transdermally but also allow the SC to return to its original
characteristics. One way to penetrate the barrier is using specific solvents that interact with the
lipids and proteins of the SC. Another way to improve the permeation of molecules is adding a
penetration enhancer or modifier to improve the number of actives diffused into the skin.
Diethylene glycol monoethyl ether (DEGEE) is a novel solvent with properties that make
it a preferred choice in dermatology and pharmaceutical products. The solvent has been reported
to improve permeation and the thermodynamic activity of an API.2,3 It has also been known to
create an intracutaneous depot with specific actives and interact with the bilayer of API loaded
vesicles to improve their permeation through the skin and ultimately deliver the active deeper
through the skin layers.4,5 Toxicology and carcinogen tests were performed, and it was found to
have no hazards, and that 99.9+% pharmaceutical grade is safe and well tolerated on the skin.6 In
industry DEGEE is used in a range of 5-40%.7 In fact, this solvent has recently been FDAapproved to a composition of 49.75%.6
DEGEE is both water miscible and a good solvent for hydrophobic materials such as skin
oils.8 More than 25 % DEGEE formulated into a topical cream improves the skin feel like
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moisturization when applied to portions of the skin that are rich in sebum (e.g., oily substance
secreted from sebaceous glands that improve the skin’s moisturization). This characteristic is
excellent for those with a skin type of oily to normal.6 However, for those with dry skin an oil-inwater formulation is required.8 Due to DEGEE’s ability to solubilize hydrophobic molecules, it
assists in the solubility of the oil phase in the emulsion.
The use of DEGEE at 25% w/w in an emulsion has caused some difficulty with
formulation scientists in formulating a stable topical product. Based on a patent completed by
Lathrope and Osborne the incorporation of Crodafos CES into an oil-in-water emulsion
containing a high volume of DEGEE was found to be stable at a wide pH range.7 Crodafos CES,
marketed by Croda, is an anionic emulsifying wax blend of ceteth-10 phosphate, dicetyl
phosphate, and cetearyl alcohol.8 This surfactant can produce liquid crystals at the oil-water
(O/W) interface which has been found to improve the overall stability, moisture retention,
controlled-release of active, and the ability to encapsulate targeted molecules in an emulsion.2,9
In this study, an oil-in-water emulsion is formulated utilizing 25% DEGEE and Crodafos
CES at a pH range 3.5 – 9.0. Polarized light microscopy is used to analyze and characterize
liquid crystals present at the O/W interface in the emulsion. The pH effect on the physical
stability was determined by a shelf-life study as well as its chemical stability confirmed by an
accelerated temperature condition at 40°C.

A. Human Skin
The human skin is composed of layers: epidermis which contains the viable epidermis,
dermis, and the hypodermis (i.e., subcutaneous tissues) which can be seen in Figure 1.10
The outermost layer of the skin, epidermis, is composed of the SC (i.e., nonviable epidermis)
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Figure 1. Layers of the human skin, specifically referencing the SC (i.e., nonviable epidermis), is
the epidermis, dermis, and hypodermis. The SC of the epidermis is composed of corneocytes,
keratinocytes, and an intercellular matrix. This layer is the protective barrier of the outermost
layer of the skin. Adapted from Ref. 10.
and the viable epidermis. The SC is composed of corneocytes (i.e., enucleated cells),
keratinocytes, and an intercellular matrix composed of lipid lamellae layers in an aqueous
environment.1 The corneocytes are elongated, flat, compacted, and dehydrated cells that are a
component of the intercellular lipid lamellae layers (Figure 2). The keratinocytes of the
epidermis are responsible for the renewal of the skin as well as to synthesize and express many
different proteins and lipids by proliferation (e.g., increase cell number), differentiation (e.g., one
cell type to another), and keratinization (e.g., cells under the skin are converted to hair and
nails).11
Intercellular Matrix. The SC is the protective barrier meant to keep water in and
noxious substances out and is approximately 10-15 cells in depth (10-20 µm) with low hydration
which is around 10-20% versus 70% found in the viable epidermis.12,13
3

Figure 2. The intercellular matrix (“mortar”), found in the SC, composed of lamellae lipid layers
between the corneocytes (“bricks”). Adapted from Ref. 12.
The SC has been described as a “wall-like” structure (Figure 2) in which the corneocytes
represent the “bricks” of the wall that are held together by intercellular lipids, or the “mortar”.11
The intercellular matrix of the SC is composed of lipids stacked in a lamellae fashion and is the
critical factor in maintaining the permeability barrier function.11 The major components of the
lipids found in the matrix are ceramides (i.e., lipids of the intercellular matrix that maintain the
skins moisture), cholesterol, and free fatty acids, with ceramides being the most abundant lipid.11
Hydration. The SC has low hydration which is around 10-20% versus 70% found in the
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viable epidermis, and to aid in the hydration of the skin the barrier maintains its hydration from
within the body. The hydration is driven by a water gradient between the water-rich tissues and
the environment surrounding the outer layer of the skin.1 Because of the difference in vapor
pressure from the environment around the skin and the skin itself, extra care is needed in
providing proper hydration to the skin. Why hydration is so important is that it can improve the
mobility of the components of the skin, lipids, and proteins, which under dehydrated conditions
become more rigid. Skin hydration is important in the ability for improved permeability of active
ingredients through its barrier, as well as the increased solubility of APIs and the decrease of the
diffusion resistance of the SC.1 For APIs that are water-insoluble, incorporating a solvent that
improves the skins solubility of hydrophobic active ingredients is key. The barrier properties of
the SC and the hydration of the skin are important factors when considering transdermal API
delivery.

B. Routes of Delivery
It is preferred that topically administered APIs act cutaneously (i.e., dermal) or
percutaneously (i.e., transdermal) into the skin. Three different functions can be targeted when
applying an API onto the skin using a topical product:13

1. The active may need to remain on the surface of the SC, such as in the cases of insect
repellents and cosmetics
2. Dermal permeation into deeper layers of the skin. Permeation of actives into the viable
epidermis and the dermis layers of the skin. This can also apply to actives that
accumulate in the skin as intracutaneous depots with little to no active flux (i.e., rate of
permeation) through the skin14
3. Systemic action of the active to be delivered via transdermal delivery where local
interaction (e.g., intracutaneous depot) is unwanted.
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Regarding targeting transdermal delivery there are four routes by which an active can be
transported through the skin. Through the pores of the skin including transfollicular (hair
follicle), transglandular (oil glands), and transepidermal, which includes transcellular (i.e.,
through the corneocytes) and intercellular (i.e., around the corneocytes through the lipid matrix),
as seen in Figure 3.11

Figure 3. Route options for permeation of APIs through the SC via pores or transepidermal.
Transepidermal includes transcellular which is a route through the corneocytes of the SC.
Intracellular route goes around the corneocytes and through the lipid lamellae matrix.
Reproduced from Ref. 13.
Hydrophilic and Hydrophobic Pathways. The intercellular lipid lamellae matrix exists
between the corneocytes, and two pathways within this matrix have been proposed: the
hydrophilic and hydrophobic pathways. Figure 4 shows both pathways an active ingredient can
permeate through within the SC. In the hydrophilic region there is an aqueous region between the
polar head groups of the fatty acids and ceramides. The hydrophobic region is found between the
tails of the fatty acids and ceramides.11
Transdermal Delivery. Percutaneous permeation, or transdermal delivery, is the passage
of an API into the SC (i.e., the outer layer of the epidermis) by the concentration gradient and its
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diffusion through the viable epidermis, which then can go through the dermis and, with
appropriate properties, into systemic circulation.15 It is important to note that most APIs are

Figure 4. Schematic representation of the intercellular matrix of the SC. There are two different
pathways an active ingredient can pass through this matrix: hydrophilic and/or hydrophobic
pathway. Adapted from Ref. 11.

Unable to pass through the skin without being combined with a vehicle having appropriate
properties (e.g., permeation enhancers, solvents, surfactants). Transdermal delivery can reduce
gastrointestinal problems caused by oral delivery, it provides a non-invasive and painless ease of
API administration, and it avoids “first-pass metabolism” and rate of absorption issues.3 It also
avoids possible infections from other delivery methods like injections.11
The transdermal delivery process begins with the release of the active from the vehicle
followed by the permeation into the SC.11 The active then diffuses through the SC by either the
hydrophobic or hydrophilic pathway which is defined as the rate-determining step based on its
diffusivity through this layer.11,15 Once through the SC the API can partition into the aqueous
environment of the viable epidermis, and if designed to, may be absorbed into the hydrophilic
environment through the capillaries of the dermis.11
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When formulating a topical product there are four properties that can influence the
permeation process and ultimately the therapeutic properties of topical products:14

1. The physical and chemical properties of the skin (e.g., skin type and condition)
2. The vehicle to deliver active to the skin
3. The physiochemical properties of the active ingredient (hydrophilic, hydrophobic, and
particle size)
4. The interaction between the vehicle and the active ingredient (related to the ability to
release the active from the vehicle to the surface of the skin)
To increase permeation, one should rely on two main approaches: increasing the SC’s
permeability, and the driving force of the active.11 An active must have the ability to penetrate
the skin and diffuse through the hydrophobic and hydrophilic properties of the SC. If the active
is too hydrophilic it will be unable to detach from the vehicle to the SC. It also cannot be too
lypophilic which will cause it to be reserved in the intercellular lipids of the SC. The active
would also need to be non-ionized for diffusion across the SC; an ionized active has a lower
permeability coefficient.11
Active Permeation. An active’s solubility and diffusivity properties establish the rate
determining steps previously mentioned. The active’s solubility determines the rate at which the
active is released from the vehicle and into the SC. The diffusivity determines the speed at which
the active propagates through each environment, which depends on such parameters as diffusion
path length and viscosity.11 The diffusivity property is defined in terms of the flux of the active
ingredient across a barrier (e.g., SC). The flux 𝐽 is defined as the quotient mass that passes
𝑚

through a specific cross-sectional area over a period of time, 𝐽 = 𝐴𝑡, as illustrated in Figure 5.16
There are two potential ways to increase the flux of an active ingredient at a constant
diffusional pathlength h based on the steady-state form of Fick’s first law (Equation 1); increase
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the diffusion coefficient D and increase the concentration of the active to increase its driving
force C0, which can all be improved by a specific solvent, and co-solvents other than water.11
𝐽=

𝑑𝑄
𝑑𝑡

=

𝐷𝐾𝐶0

(1)

ℎ

where K represents the partition coefficient of the vehicle, and Q is the amount of active
ingredient permeating a given area of the skin.11

Figure 5. Schematic representation of molecules passing through a cross-sectional area which
visually represents the flux of an active ingredient. Reproduced from Ref. 16.

C. Penetration Enhancers (PE)
Enhancement of penetration and permeation of an active can be done physically,
chemically, or by use of a formulation product.13 The use of a chemical enhancement to improve
the permeability of an active is to incorporate a chemical penetration enhancer, or permeability
enhancer. A penetration enhancer (PE) is an inactive vehicle that interacts with the SC in a
reversible way to aid in the penetration and permeation of an active ingredient.11,17
Penetration enhancers create microcavities within the lipid bilayer of the SC
homogenously (i.e., free volume cavities dispersed evenly throughout the lipid bilayer) or
heterogeneously (i.e., concentrated “pores” formed in the lipid bilayers creating a least resistant
pathway for hydrophobic molecules) allowing free volume for API diffusion.17 They rely on the
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lipid-protein-partitioning (LPP) theory of skin penetration enhancement, which indirectly
increases the thermodynamic activity of the vehicle or increases the solubility characteristics of
an active in the formulation.11 Barry (1991) proposed the LPP theory that describes the possible
mechanisms on how penetration enhancers alter the SC for permeation of the skin. The LPP
theory suggests three possible mechanisms: lipid modification, protein modification, and
permeation promotion.18
Under lipid modification the penetration enhancers are believed to interact with the lipid
bilayer of the SC at three main sites: interacting with the polar head groups, aqueous domain of
the lipid bilayer, and interacting with the lipid alkyl chain.17 When an enhancer interacts with the
polar head groups by forming hydrogen bonds causes a disruption of the “hydration spheres” of
the polar head groups. This disrupts the packing order of the lipid bilayer making the lipids more
fluid and increases the volume of the water within the planes of the bilayer which decreases the
resistance of the APIs diffusion.17 The interaction with the lipid alkyl chains increases the lipids
fluidization when the penetration enhancer inserts itself between the hydrophobic tails of the
lipids in the bilayer. This disruption of the packing order increases the active’s diffusion through
the SC.17
When the penetration enhancer interacts and binds with the keratin filaments found in the
corneocytes its defined as protein modification (i.e., interaction with intracellular protein of the
SC, intracellular route) under the LPP theory. The interaction denatures the keratin and causes a
conformational change of the protein creating vacuoles for active diffusion, by swelling and
increasing the hydration of the SC.17
During permeation promotion (i.e., increasing permeation of an active) certain solvents
(e.g., ethanol, DEGEE, propylene glycol) can interact with the aqueous domain of the lipid
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bilayers, penetrate the SC, and change its chemical properties (i.e., solubility properties) which
allows for an increase in actives diffusion into the SC.17 This interaction increases the solubility
within the SC by matching the solubility parameter of the skin to the API allowing for an
increased partitioning of the active from the vehicle into the SC.17 Lipid modification and
permeation promotion are the two mechanisms that have been found to be characteristic of the
novel solvent DEGEE.

D. Diethylene Glycol Monoethyl Ether
Transcutol is the tradename for the official United States pharmacopeia name, diethylene
glycol monoethyl ether, or DEGEE for short.6 It may also be listed as ethoxydiglycol in an
ingredient list in agreement with the international nomenclature of cosmetic ingredients (INCI)
dictionary.6 The use of DEGEE in topical products has increased recently due to its ability to
solubilize active ingredients that are insoluble in common solvents. DEGEE can be utilized at a
safe concentration at an amount that avoids irritation issues.19 However, it can also promote the
transfer of skin irritant excipients that are formulated in topical products.17 DEGEE is formed by
the ethoxylation of ethanol, and its structure can be seen in Figure 6.

Figure 6. Chemical structure of diethylene glycol monoethyl ether (CAS No. 111-90-0)

Toxicology. Toxicology reports on DEGEE performed by Hardin20 analyzed the material
at a 98% purity level, which was found to have adverse effects on rat species when ingested.
Ingesting DEGEE caused male rat infertility and testicular atrophy20. Thus, prior to the 1990’s
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DEGEE was found to be highly toxic. These toxicity affects were most likely caused by the
ethylene glycol impurity in the lower grade versions available.19 Now the USP-NF (United State
Pharmacopeia and National Formulary) grades of DEGEE are >99.9% in purity and have been
found to give negative results in genotoxicity testing both, in vitro and in vivo.11,19
Routes of Use. Table 1 lists the solvent’s current percent compositions found in various
types of product formulations, according to the IID database on the Federal Drug Administration
(FDA) website.21 As seen in the list; the FDA has approved the use of DEGEE up to 49.91 %
(w/w) in a topical gel formulation.

Table 1. Route, dosage, and potency of DEGEE. Information provided by the FDA (updated
as of April 12, 2019)*
Route
Dosage form
Potency/amount (unit)
Topical

Cream

15 (%w/w)

Topical

Emulsion, Cream

15 (%w/w)

Topical

Gel

49.91 (%w/w)

Topical

Lotion

1 (%w/w)

Transdermal

Gel

5 (%)

Transdermal

Patch

430 (mg)

*Retrieved from Ref. 21.

E. Benefits of DEGEE
DEGEE has been found to improve the permeation of APIs through the SC, improve the
solubility of the active, create intracutaneous depots in the layers of the skin, as well as other
attractive properties mentioned below.
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Inhibits Proliferation. In a study completed by Levi-Schaffer and co-workers22 found
DEGEE inhibits proliferation towards skin diseases. This characteristic was found by studying
human normal and psoriatic dermal fibroblasts that were donated from volunteers. 3T3 Swiss
albino mouse and human fibroblasts were cultured and incubated in several different compounds,
including DEGEE. Murine lymphoma cell line YAC and murine mastocytoma cell line P-815
were also assayed for viability and numbers for fibroblasts. It was found that DEGEE increases
the inhibition of rapid cell production and was highly effective in inhibiting proliferation of P815 tumor cells and it was not cytotoxic.22
Improved Permeation. Gannu and co-workers3 found that DEGEE improved the
permeation of an active and the potential of the solvent to be a vehicle for transdermal delivery.
They completed their study in vitro by using porcine skin and a Franz diffusion cell. The
mechanism of permeation by DEGEE was theorized to compete with the hydrogen bonding of
terpenes with the ceramide head groups in the lipid lamellar bilayer matrix. It is possible that the
interaction breaks the lamellar hydrogen bonds within the bilayer matrix of the SC, causing a
new polar pathway of channels.3
Improved Thermodynamic Activity. During a modified vertical Franz diffusion cell
(Figure 7) study utilizing whole and stripped dorsal male rat skin, Ganem-Quintanar and coworkers2 evaluated the rate of DEGEE-water interchange. An experiment in which the inflow of
DEGEE and outflow of water were measured in a uniform distribution across the donor, skin,
and receptor compartments of the cell was completed. Before permeation DEGEE was placed in
the donor compartment, water in the receptor, and pig skin between each compartment.
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Figure 7. Schematic representation of a vertical Franz Cell. Before permeation DEGEE is found
in the donor compartment. After permeation DEGEE + Water is found in both donor and
receptor compartments. Adapted from Ref. 2.

After permeation, DEGEE was found in the receptor compartment, which indicates that
the solvent does pass through the skin. Water was found in the donor compartment which
influences the API’s solubility by improving the skins hydration which improves the
thermodynamic activity (i.e., the potential of the active to be released from the vehicle to the
skin) of the active. The transfer of water to the donor was likely due to DEGEE’s hygroscopic
properties (i.e., absorb moisture from the air). The inflow of DEGEE and outflow of water across
all compartments improved the moisturization of the skin and influenced the active’s solubility.
It is possible that DEGEE alters the barrier properties of skin by substituting for water molecules
in the SC and thereby affecting the active’s ability to penetrate.2
Intracutaneous Depot. Ritschel and co-workers5 found that that DEGEE decreased the
permeation of an active across the skin but increased the penetration of the active into the skin,
which shows promise for targeting specific actives into the skin. They completed their study
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using the actives, dexamethasone, and hydrocortisone. DEGEE was formulated into a gel and
was evaluated in vivo using rats. They observed the binding of the active to the skin in both full
thickness (epidermis + dermis) and full epidermis with the dermis removed (epidermis + SC)
samples. Their results showed that the amount of both actives bound to the skin was similar in
the full thickness and epidermis + SC samples (e.g., amount of API, µg/mg in the presence of
50% DEGEE). This would mean that an intracutaneous depot of active is found in the epidermis
+ SC. During the autoradiography review they found that hydrocortisone was uniformly
distributed in the skin in the presence of DEGEE versus localization of the active in the
epidermis and hair follicle only when not treated with DEGEE.5
A similar study by Otto and co-workers23 observed that DEGEE increased the skin’s
retention of the hydrophobic APIs, dexamethasone, and hydrocortisone. The permeability by
transdermal delivery decreased, which indicates an intracutaneous depot. This was based on the
knowledge that the addition of a penetration enhancer (PE) in a topical formulation or directly on
the skin can determine the driving force for diffusion across the skin. Solubility of the active by
the PE in the formulation increased which coincidently reduces the penetration through the skin
due to the active’s affinity for the vehicle. For this reason, the solubility of an active ingredient
needs to be compensated for the addition of the penetration enhancer so that the maximum
thermodynamic activity of the active can be achieved while reducing the attraction between the
active and vehicle.
Vesicle Deformability. A study completed by Manconi and co-workers4 described
DEGEE as an “edge activator”, which improved the deformability of vesicles by interrupting the
phospholipid packing in its bilayer causing it to become more elastic. This is important due to
the vesicle’s ability to squeeze through a small pore as a result of its bilayers becoming
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deformed. DEGEE was found to create an intracutaneous depot of the active-loaded vesicles
which allowed the vesicles to reach the epidermis, and then could travel independently deeper
into the layers of the skin. This was found by preparing vesicles, liposomes, and penetration
enhancement vehicles (PEVs), both empty (control) and active-loaded (diclofenac). High
performance liquid chromatography was utilized to verify the amount of active loaded in each
vesicle, and the deformability of vesicles were carried out by the extrusion method (e.g.,
reducing the vesicle from multilamellar to unilamellar by passing them through a membrane
filter). Skin permeation studies were completed ex vivo by Frans Diffusion vertical cell analysis
utilizing newborn pig skin.4 It was found that PEVs in the presence of DEGEE always showed a
smaller vesicle with a more negative zeta potential for both empty and loaded vesicles compared
to PEVs without DEGEE. A more negative zeta potential tends to prevent the aggregation and
fusion of vesicles, which indicates better stability.4
Manconi and co-workers hypothesized that DEGEE interacts with the initial portion (i.e.,
outside layer of the vesicle) of the hydrophobic tails of the vesicle rather than deep into its
bilayers, because of steric hinderance between its polar headgroup and short hydrophobic chain.
This allows the polar head of DEGEE to stick out from the vesicle and interact with the water
molecules. Manconi and co-workers observed this characteristic of DEGEE during rheometric
studies looking at viscosity variations in vesicles versus temperature change. At specific
temperatures, the vesicles transformed from a paracyrstalline, gel-state structure to a liquidcrystal structure. With increasing temperatures, the vesicle changed from a low-viscous, rigid
gel-state bilayer to a more fluid liquid-state bilayer. The presence of DEGEE decreased the
overall transition temperatures of the vesicles, thereby causing an interruption of the
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phospholipid characteristics, fluidizing the vesicle’s bilayer, and improving permeability of
active-loaded vesicles.4
Benefits Summarized. It has been found and hypothesized that DEGEE is
hyperproliferative towards skin diseases22, improves the moisturization of the skin2, and
decreases the permeation of an active across the skin while increasing the penetration of the
active into the skin.15,17 DEGEE interacts with the aqueous domain of the lipid bilayer by
matching the solubility of the active to the solubility parameter of the skin, which improves the
permeation (partition coefficient) of the active from the vehicle into the SC.6,17 DEGEE increases
the solubility of the active within the SC, creating an intracutaneous depot and maximizing the
active’s thermodynamic activity.2,6,23 Finally, DEGEE has been determined to be an “edge
activator,” improving the deformability of loaded vesicles.4
Due to these desirable features of this specific solvent, we have formulated DEGEE into
an oil-in-water emulsion. The definition of an emulsion and the types of dispersions for topical
use will be discussed.

F. Emulsions
DEGEE, along with other components, was incorporated into an oil-in-water (O/W)
emulsion (Table 2). An emulsion is a liquid-liquid dispersion in which large droplets (micron
size) of one liquid are suspended in a continuous phase of another.24 Emulsions, microemulsions,
and nanoemulsions are three main types of dispersions to consider when formulating a topical
product. Each can contain an oil phase, aqueous phase, a stabilizing surfactant (emulsifier), and
in some cases a co-surfactant.25
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Table 2. Formulation of O/W emulsion containing DEGEE
Ingredient

Tradename

Wt%

Water Phase
Deionized water

49.75*

1.00 N NaOH (aq)
Oil Phase
White Petrolatum USP

10.0

Isopropyl Palmitate

Crodamol IPP

5.0

Emulsifier blend

Crodafos CES

10.0

DEGEE Phase
(Cetearyl alcohol, dicetyl phosphate, and ceteth-10
Diethylene Glycol Monoethyl Ether
phosphate)
Methyl Paraben

Transcutol P

25.0

Propyl Paraben

0.20
0.05

Total
100
*A specific amount of 1.00 N NaOH (aq) is added to the water phase which is then diluted to
a combined total of 49.75 wt % of the total cream formulation.
Stability Testing. The stability of a dispersion is important both during and after
formulation. The stability of an emulsion is determined based on the observed changes in particle
size, and the droplet density versus the density of the medium in which they are dispersed.26
There are physical and chemical properties that should be tested after the formulation of the
topical product before it moves to production. Tables 3 and 4 list the types of properties and test
methods used to determine a dispersion’s stability. The emulsion tests listed in Table 4 provide
information regarding the effects of shipping and storage on the product in its container. The
properties monitored during stability testing are vast and it is understood that ideally all property
methods should be utilized (Table 4). However, access to all instruments may not be feasible for
some formulators. Often pH, viscosity, odor, flow behavior, and separation are the typical
physical properties analyzed at room and elevated temperatures.27
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Physical Breakdown. If an unstable dispersion is formulated, its shelf-life is limited, and
physical breakdown can occur (Figure 8). The center square of Figure 8 represents the emulsion
in its homogenized colloidal state. Creaming can occur by gravitational or centrifugal force. For
instance, if an external force on the system is greater than the Brownian motion (i.e., thermal
motion), separation of the cream into separate phases based on the density will occur. The more
phases that separate (e.g., aqueous, oil, solid phase), the more unstable is the emulsion. The
denser phases will be found at the bottom of the separated emulsion, whereas the less dense
particles will be at the top.26 Creaming by centrifugal force is of interest in this study.
As suggested by Friberg and coworkers24, the application of mixed surfactants (e.g., Crodafos)
can form a mixed surfactant film that, under the right conditions, will produce multiple bilayers
covering the suspended droplets in solution. These multiple bilayers constitute a liquid
crystalline phase (i.e., multilayered structures) that lowers the potential drop in the Flocculation
process, thereby reducing the van der Waals attraction between droplets.

Table 3. Conditions tested for emulsion stability
Storage Conditions

Storage Period

Ambient temperature

25 °C for 3 yrs

Elevated temperature

37 °C, 45 °C 6 mths

Refrigerator

4 °C 3 mths

Freeze/thaw cycles

5 at -10 °C to ambient

Cycling chamber

4 °C to 45 °C in 48 hrs for 1 month

Light exposure

Light cabinet*

*Light cabinet or 1-month exposure to north-facing light, adapted from Ref. 27.

19

Table 4. Properties monitored during the conditions test*
Property

Test Method

pH

pH meter

Viscosity

Rotational viscometer

Flow behavior

Oscillatory shear viscosity

Tack/Texture

Extensional and compressional deformation

Color

Visual or colorimeter

Odor

Organoleptic

Specific gravity

Pycnometer

Separation (creaming)

Visual or instrumental

Conductivity

Conductivity meter

Droplet size distribution

Microscopic image analysis and instrumental

Preservation

Microbial challenge and/or assay

Vibration

Shipping test or shaker table

Active ingredient(s)

Chemical or bio-assay

Lyotropic liquid crystal

Polarized light microscopy

*Adapted from Ref. 27.

G. Surfactants
Surfactants have been defined as “surface-active agents” and have the ability to stabilize
interfaces in an emulsion and self-assemble into specific structures. Surfactants can stabilize
interfaces by lowering interfacial tension between two liquids, a liquid and a gas, and liquid and
a solid.26 Surfactants consist of two parts, a hydrophilic (polar) head group and a hydrophobic
tail. This allows the compound to have both water-soluble and water-insoluble components and
are often utilized in colloidal systems.28
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Figure 8. Visual representation of multiple breakdown processes that can occur in dispersion
based on its stability. Reproduced from Ref. 26.

There are four classifications of surfactants: anionic, cationic, nonionic, and amphoteric.
In this study the surfactant used is an emulsifying wax blend of an anionic surfactant and fatty
alcohols (cetearyl alcohol, dicetyl alcohol, and ceteth-10 phosphate) and is marketed by Croda
Personal Care (East Yorkshire, UK) under the tradename, Crodafos CES. It presents as a white,
waxy solid and is known to form a liquid-crystal-stabilized emulsion that can be formulated at a
wide range of pH values.8 Anionic surfactants in general are more effective than cationic or
nonionic surfactants for increasing the skin permeation characteristics of certain molecules.
Anionic surfactants carry a negative charge on the hydrophilic portion of the molecule and
interact with the lipid and keratin components of the SC.29,30
Self-Assembly. A characteristic of surfactants is their ability to self-assemble into
specific structures (e.g., micelles and lyotropic liquid crystals). Before self-assembly occurs, the
surfactant monomers begin to absorb at the different interfaces and consequently reduces their
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interfacial tension.30,31 As a surfactant is added to an emulsion the monomers will begin to form
a monolayer at the energetically favored air-water (A/W) interface with the hydrophobic tails
sticking out into the gas phase (i.e., air) and the hydrophilic heads submerged in the water
phase.31 This will replace the highly structured hydrogen bonds of the water phase with weaker
van der Waals structured hydrocarbons (Figure 9).31 Once the A/W interface is completely
saturated the free monomers will begin to absorb at the oil-water (O/W) interface. This causes
the oil droplets to reduce their size and become more stable. Once all the interfaces are
completely saturated the free surfactant monomers are forced to collect in the bulk phase of the
solution (Figure 10). Due to the alkyl chains lack of affinity to water it prefers to interact with
itself forming entities known as micelles.32 The bulk solute concentration at which micelles
begin to form is known as the critical micelle concentration (CMC), and the driving force for the
self-assembly process is known as the hydrophobic effect.31,33

Figure 9. Schematic representation of a surfactant molecule at two simple interfaces.
Hydrophobic tail resides in the oil or air phase, and they hydrophilic head resides in the water
phase. Reproduced from Ref. 31.

Emulsification. Tadros26 provided a visual representation of the processes that occurs
during emulsification and how surfactants play a role at the O/W interface reducing the droplets
size in the emulsion (Figure 11). The bold lines and dots around the droplets represent surfactant
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Figure 10. Schematic representation showing a surfactants reaction to the increased concentration
of added surfactant molecules to the bulk phase solution. Reproduced from Ref. 29.

Figure 11. Visual representation during emulsification and the role of a surfactant. Solid lines are
the drops, and the surfactants are represented by the thicker lines and dots. A) Emulsification, B)
surfactants surround smaller droplets, and C) show surfactant adsorbed droplets collide but do
not coalesce. Reproduced from Ref. 26.

Molecules, while the non-bold lines represent the droplets in the emulsion. Process A represents
the breakup of a larger droplet into smaller droplets during emulsification. The surfactant
molecules surround the drop, lowering the interfacial tension and reducing the stress needed to
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break up and reduce the droplet size. During process B the surfactant adsorbs between the oil and
water interface of the droplets. The final process C represents the collision of droplets and how
the surfactant reduces the chance of coalescence.26
The Hydrophobic Effect. The hydrophobic effect occurs due to the hydrophobic
portions of the molecules lack of affinity to water. The affinity of the hydrocarbon to itself is
similar to water’s affinity for other water molecules.34 This minimizes the interface between the
hydrophobic portion of the molecules and the water molecules. The hydrocarbon molecule
causes an increase in the degree of structure in the surrounding water molecules.31 Even though
water has a strong polarity, one important feature of water is its tendency to hydrogen bond.
Water therefore rearranges its structure to form cages around the solute. By this action water
becomes more ordered, which occurs for smaller solute molecules. If larger solute molecules are
present, then the connections (hydrogen bonds) between adjacent water molecules in solution
must be broken. If the dissolved solute molecule is unable to form hydrogen bonds with the
surrounding water molecules the entropy change for that system is very costly.32
Critical Micelle Concentration. The CMC is a concentration level between surfactant
monomers and water where interacting monomers begin to form aggregates (Figure 12). In this
figure, the surface tension is seen to decrease until the surfactant concentration and water ratio
reaches the CMC value which then stabilizes. The turbidity (i.e., micelles solubility limit)
sharply increases. The increase in turbidity decreases the solutions (i.e., micelles and water)
clarity then becoming opaquer, and supports the moment micelles begin to transform into new
structures.35 As micelles exist as separate entities in solution and the surfactant concentration is
increased repulsive and attractive interactions occur between aggregates (i.e., micelles).
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Figure 12. Represents the physical properties that are dependent on concentration of a surfactant
that forms micelles. Reproduced from Ref. 33.

The attractive interactions between aggregates causes them to condense into a separate phase
from the dilute aqueous solution (e.g., turbidity increases). The repulsive interactions force the
aggregates shape to change to create more distance between aggregates. The result of the
repulsion causes a transition between phases (mesophase): spherical micelles → cubic phase, rod
micelles → hexagonal, and disk micelles → lamellar phase, as shown in Figure 13.36 The
schematic also shows the trend in the size of head groups and curvature of each phase going
from highest to lowest. These aggregate shapes are known as liquid crystals and have been found
to improve the stability, moisture retention, controlled release of active, and the ability to
encapsulate targeted molecules, in particularly, those in the lamellar phase.9

H. Lyotropic Liquid Crystals
A lyotropic liquid crystal (LLC) is a liquid crystalline state that carries a sense of fluidity
while maintaining some structural uniformity.32
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Figure 13. Schematic representation of the mesophases that can occur with an increase in
surfactant concentration. Reproduced from Ref. 36

The internal structure of an LLC is composed of hydrophilic and hydrophobic domains, and a
lipid bilayer. Due to these characteristic domains LCs have been found to encapsulate a variety
of amphiphilic, hydrophilic, and hydrophobic active ingredients, which can protect APIs from
hydrolysis and enzymolysis.37
The term lyotropic defines a material that forms a crystalline phase upon the addition of a
solvent. Before a lyotropic liquid crystalline phase can form, a few interactions take place, and
the role of the solvent is realized. Water is often considered an exceptional solvent due to its
polarity and inter-molecular hydrogen bonding. The hydrogen bonding between water molecules
allows for a vast number of configurations. The possible range of structures allows for a large
amount of free volume between neighboring water molecules.31 The structures of LLCs depend
on a variety of parameters: pH, temperature, light, magnetic field, water content, additives, and

26

the type of amphiphile.37 In this study the effects of pH and temperature on the formation of
LLCs are assessed.
Critical Packing Parameter. There is some predictability and accuracy in determining
the kinds of possible structures formed which is possible if the structures geometrical shape and
background are clarified. These parameters can then be applied to a ratio rule, also known as the
critical packing parameter (CPP), to accurately predict the structures formation. This is an
important concept in determining principal structures that can be formed (e.g., micelles and
lyotropic liquid crystals) in solution. The CPP can be defined numerically as CPP = v/al, where
v represents the real volume of the hydrophobic chain, a represents the cross-sectional area of the
hydrophilic head group (+ ½ distance to its closest neighbor), and l represents the approximate
length of the hydrocarbon in its molten state (Figure 14).38

Figure 14. Geometric representation of a surfactant monomer utilized in the CPP calculation.
This allows for some predictability and accuracy when determining the formation of aggregates.
Reproduced from Ref. 38.
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The geometric measurements utilized in the CPP formula produce a ratio value
determining the structures shape (Table 5). To relate the CPP to this study, a system containing
water and a long-chain alcohol of an ionic surfactant three structures form consecutively. At first,
1

the ionic surfactant forms spherical micelles (CPP value is < 3) in the aqueous solution. This
structure is expected due to the repulsive forces between the polar groups of the ionic surfactant,
and as a consequence a large a value in the CPP ratio.31,38 With a long-chain alcohol and an ionic
surfactant lamellar packing is favored. This is a result of the OH group of the alcohol and the
charged group of the surfactant. The OH group has no repulsion to the charged groups of the
surfactant and will fit into the space between them.31,38 This results in a large reduction of the a
1

value, no reduction of v, producing CPP 2 ↔ 1. Continuing the addition of an ionic surfactant
and long-chain alcohol results in the continued reduction of the a value and inverse phases of
LLCs occur.31,38
Improved Moisture Retention by LLCs. Zhang and Liu9 theorized the improved
stability and moisture retention with the formation and the increased volume percent of LLCs in
an O/W emulsion. Moisture retention, relative to this study, can be defined as the final quantity
of condensed water diffusing across the SC. They also investigated the water content (i.e.,
hydration) of the cells before and after the application of the emulsion. Each study applied
emulsions containing different percent volume of LLCs (e.g., 2%, 4%, 6%, and 8%) to the skin
to measure its moisture retention and hydration via a Transepidermal Water Loss (TEWL) and a
corneometer. A corneometer was used to measure the hydration level of the SC via dielectric
properties by passing an electric field through the SC and measuring the water content within the
skin cells.39 The TEWL measured the moisture retention by quantifying the amount of condensed
water diffusing across the surface of the SC per unit of time.40
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Table 5. Changes in the critical packing parameter. Adapted from Ref. 32,39.
R-value Name
Surfactant Type
Shape
Structure Formed

Spherical
1
<
3

1 1
↔
3 2

aqueous
micelle

Single-chain with large head
group

Cylindrical or

Single-chain with small head

Rod-shaped

groups, or ionic with

micelle

electrolytes present

Vesicles and
1
↔1
2

Flexible

Double-chain with large head

bilayers

group, flexible chain

(Lamellae)

1

>1

Planar bilayers

Double-chain small or rigid
head group, immobile chain

Inverse

Double-chain with small

cylinder or

head group, bulky

micelle

hydrophobic groups
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It was found that no change in the hydration level of the cells in the SC occurred over
time. However, the moisture retention of the SC improved as the percent volume of LLCs
increased in the emulsion. This would suggest that the improved moisture retention properties of
the emulsion could be due to LLCs ability to entrap water molecules within the ordered structure
of the LLC by interacting with the hydrophilic portions of the surfactant molecules.9
Improved Emulsion Stability by LLCs. The Crodafos CES surfactant used in this study
is known to form multilayered LLCs that surround oil droplets providing stability to coalescence
(i.e., oleosomes) (Figure 15).41 The remainder of the LLCs produce a network that form
throughout the continuous phase (i.e., hydrosomes), which exhibits viscoelastic behavior.41 The
oleosomes formed can be observed visually under polarized light microscopy as ‘Maltese
Crosses’.7,38,42

Figure 15. Schematic representation of an oleosome (left) and a hydrosome (right). Reproduced
from Ref. 7, 38.

Friberg and co-workers43 completed a study showing that the formation of LLC
multilayers around oil droplets at the O/W interface reduces the chance for flocculation and later
coalescence. The LLC multilayers act as a protective barrier between two oil droplets which
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lessen the van der Waal attraction potential and ultimately improve the overall stability of the
emulsion. Figure 16 shows a schematic that illustrates an uncovered droplet versus a
multilayered LLC-covered droplet. When comparing an uncovered droplet going into the
flocculation step An → F and an LLC-covered droplet going into the flocculation step Ac → Mc,
it can be seen that several monolayers from the LLC-covered droplet would need to be removed
before flocculation could occur. The presence of the LLC reduces the potential drop by
absorbing almost all of the potential energy available (~75%) to reach the common state F prior
to step Ac → Mc (Figure 17). Only (~25%) of the potential energy is available for coalescence to
occur Mc → F compared to an uncovered droplet which has 99.7% of the potential energy
available for thinning of the viscous film. The LLC surrounding the oil droplet has a higher
viscosity than for the oil itself which further enhances the emulsions overall stability.43

Figure 16. Uncovered vs LLC-covered oil droplets. O = oil, W = water, │m│= monolayer, d =
distance between droplets. Adapted from Ref. 43.
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Figure 17. The solid lines represent the distance between uncovered droplets surfaces. The dotted
line represents the distance between LLC-covered droplets. Adapted from Ref. 43.

Microscopic View. Microscopic View is a term designated by the Food and Drug
Administration (FDA) to describe using polarized light microscopy (PLM) to determine API
particle size and bright-field microscopy (BFM) to determine globule size. Microscopic View
provides a rapid and accurate analysis of a topical product without the use of chemical analysis
and is required by the FDA if the product is an emulsion. It is also recommended when globule
size or API particle size is a Q3-critical quality attribute (CQA) of the active product (i.e., an
attribute that corresponds to an appropriate range and equivalent microstructure to ensure an
equivalent product).44
Polarized Light Microscopy. PLM can determine the presence of birefringent material
due to the material’s anisotropic properties. Anisotropic materials (e.g., lamellar LLC) contain
two different refractive indices, an ordinary and extraordinary ray (Figure 18). This inequality of
refractive indices is due to the difference in characteristics between the grain boundaries of the
crystal. The greater the difference between the refractive indices generates an increase in
scattering of the transmitting light which causes a decrease in transparency of the material (i.e.,
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rise in opaqueness). This analysis is achieved by utilizing a microscope fitted with a polarizer
and analyzer as seen in Figure 19.

Figure 18. Schematic representation of unpolarized light going through a birefringent material
that creates two refractive indices, ordinary and extraordinary. Reproduced from Ref. 45.

The light source from the microscope will pass through the polarizer, creating polarized
light. The polarized light goes through the birefringent material, which produces the ordinary and
extraordinary indices (Figure 18). The analyzer then recombines the two indices creating a
colorful representation of the birefringent material.44

Figure 19. Schematic representation of a trinocular polarized light microscope fitted with a
digital camera. Adapted from Ref. 44.
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Maltese Cross. The molecular structure that forms the LLC determines the structure’s
electric responsiveness (i.e., birefringence). This response is distributed throughout the structure
and affects its polarized image.45 If the structure is defined as anisotropic then its electric
responsiveness is caused by the elongated monomers (e.g., surfactants) oriented in the LLC.46
The elongated monomers create a dipole moment from the electric waves vibrating parallel and
perpendicular (i.e., ordinary, and extraordinary indices, respectively) to the plane of the
molecule. The wave vibrating parallel to the elongated monomer is much larger than the
perpendicular wave, which causes the LLC to be birefringent.46
Bellare and co-workers46 defined how the image created by a lamellar structure is created
based on the surfactant molecules’ electric responsiveness. The surfactants that make-up the
lamellar structure organize as a homogeneous disk of a specific thickness. When the disk is
perpendicular to both the polarizer and analyzer its transmitted intensity is maximized, while
being parallel the intensity is minimized. The dark portions of the lamellae are due to molecules
being parallel to the polarizer or analyzer directions (Figure 20). Thus, a ‘Maltese cross’ image is
produced from layers of anisotropic material that are separated by isotropic material,46 and an
observation of such a feature in a Microscopic View experiment is considered to be an indication
that lamellar structures are present in an emulsion.42

Figure 20. Drawing of a Maltese cross to show the areas of birefringence and isotropy. Redrawn
from Ref. 42.
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I. Thesis Statement and Purpose
A moisturizing cream containing a high concentration of a novel solvent can be stabilized
by the formation of lamellar LLCs. This is determined by incorporating an anionic surfactant that
is known to form lamellar LLCs across a wide range of pH values. The physical and chemical
stability of this emulsion is determined across a full topical cream pH profile, and its overall
character and stability is attributed to the presence and abundance of lamellar LLCs.
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CHAPTER II: MATERIALS AND METHODS

A. Materials
Chemicals. Emulsifier: SP CRODAFOS CES MBAL-PA-(MH) mix of ceteth-10
phosphate, dicetyl phosphate, and cetearyl alcohol (C16-18) surfactant from CRODA (Edison,
NJ, USA). Emollient: Super refined® Crodamol isopropyl palmitate-IPP-L-Q-(JP) provided by
CRODA (Edison, NJ, USA), white petrolatum consumer grade (Springfield, MO, USA).
Solvent: Purified water, diethylene glycol monoethyl ether with a trademark name of
Transcutol® HP provided by Gattefosse sas (Saint Priest-Cedex, France). Preservative: Methyl
4-hydroxybenzoate 99%, propyl 4-hydroxybenzoate 99+% purchased through Acros Organics
(New Jersey, USA). pH adjuster: Aqueous sodium hydroxide, 1.0 molar concentration.
Instruments. Topical creams were mixed using a power control viscosity propeller (IKA
Eurostar). Centrifugation was completed by a (Sorvall RC-58) refrigerated superspeed centrifuge
using a (5S-34) fixed angle rotor. The pH was analyzed using a (Mettler Toledo) InLab FlexMicro pH combination electrode. Microscopy was completed using either an (Amscope PZ300)
or a generic metallurgical microscope similar to a (Nanjing Jiangnan Optics Co. NJF-120A),
both having polarization capabilities. A microspatula was used to spread a small amount of
cream onto the glass slide. Micrograph images were recorded by using (ScopeImage 9.0)
professional imaging software. Micrograph scales were calibrated by imaging a (USAF 1951)
test target. Microscope was used to observe samples heated on a low-profile cooling and heating
stage (Bioscience BTC-SL-128x80). The temperature is controlled by a 2-channel temperature
controller (Bioscience TC-1-100i) with a self-adjusting stability of 0.01°C and 0.1°C accuracy.
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B. Methods
Cream Formulation. Topical creams were formulated using a composition and process
provided by Dr. David Osborne (Table 3).4 The oil and water phases were mixed in separate 150
mL beakers. The water phase was transferred into a 250 mL Wheaton bottle, and both phases
were placed into an oven set at 85°C to bring both phases to a temperature above 70°C. The
parabens and DEGEE were measured into a 150 mL beaker and stirred at ambient conditions on
a stir plate until complete dissolution of the preservatives. Once the oil and water phases reached
a temperature above 70°C the emulsification process began.
The water phase was poured into a 400 mL beaker and measured to verify the amount of
water phase utilized in the emulsion. The 400 mL beaker containing the water phase was quickly
placed under the viscosity propeller and stirred at 455 rpms. The oil phase was then carefully
poured into the water’s vortex created by the propeller. The DEGEE and preservatives were then
added to the oil/water mixture, and stirring continued until the mixture’s internal temperature
cooled to 47°C – 49°C. The emulsion was then poured into five 70 mL storage containers and
left to sit for 24 – 48 hours before centrifugation.
Centrifugation. After the 24 – 48 hour setting time, 30 g of the emulsion was placed into
a 50 mL centrifuge tube and centrifuged at 20,000 rpms (~48,000 g) for 2 hours. After
centrifugation the emulsion was separated into two or three phases (Figure 21).47 At pH values in
the range 2.0 to 5.0, two phases were produced, an aqueous phase and a cream layer, while at pH
values in the range 8.0 to 10.0, three phases were produced, aqueous, cream, and oil phases. For
all samples, the aqueous phase exhibited the highest density and was found at the bottom of the
centrifuge tube, while the oil phase (when present) exhibited the lowest density and was found at
the top.
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Figure 21. Diagram of the phase separation that occurs during centrifugation. The centrifuge
tubes are fitted at an angle into a fixed-angle rotor (left). When the centrifuge tubes are removed
from the rotor and set at an upright the phases remain at an angle (right). Adapted from Ref. 47.

Removal of Aqueous Phase. The aqueous phase was removed from below the solid
phase by carefully tunneling through the solid phase using a microblade spatula. A glass
micropipette was guided down the same path to remove the aqueous phase. The water phase was
transferred to a 5 mL beaker, and its mass and pH were measured.
Accelerated Shelf-Life Study. About 20 g of each sample were placed into two separate
scintillation tubes to be analyzed for physical stability (e.g., creaming). Of the two scintillation
samples, one tube was placed under a fume hood at ambient conditions while the other tube was
placed in an oven set at 40°C for accelerated aging studies. The mass and pH values of each
sample (ambient and accelerated) were analyzed at 30 days and 60 days.
Microscopy. A small portion of the cream was spread thinly onto the glass slide using a
micro spatula. A derm spreader with a center depth of 0.15 mm produced a film too thick for
viewing transmission images. Under polarized light microscopy, the birefringence was too blurry
due to the multiple layer’s birefringence. A glass cover slip was not used to ensure that no
mechanical alteration of the lyotropic liquid crystals occurred. The contents on the slide were
analyzed under the microscope using polarized light imaging (transmission mode). Each sample

38

was investigated with objective magnifications of 4x, 10x, and 40x. Combined with the
approximately 22x magnification of the digital camera, these objectives corresponded to total
magnifications of 88x, 220x, and 880x, respectively. For samples used during the hot stage
observation the stage is outfitted onto the viewing base of the microscope. A temperature
controller raised the heat of the hot stage to temperature ranges up to 45°C.
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CHAPTER III: RESULTS AND DISCUSSION

Ultracentrifugation techniques and accelerated temperature conditions have been
described to predict the physical and chemical stabilities of a finished cream, respectively. Just as
storage of a cream at 40°C is an accelerated temperature study for its overall chemical stability,
centrifugation is an accelerated gravity condition to predict the cream’s physical stability. The
difficulty to break a cream (i.e., separate the cream into distinct phases) by centrifugation can be
used as a measure of the cream’s physical stability, while a cream that maintains its pH value
through an accelerated shelf-life study is said to indicate chemical stability.48
PLM has been employed to detect birefringence in the emulsions at variable pH values.
Birefringent patterns show that the Crodafos CES emulsions have anisotropic properties over the
entire pH profile. Not all LLCs exhibit birefringence. Those that do are hexagonal and lamellar
microstructures, and both are easily discernable under PLM.

A. Physical and Chemical Stability
Formulating with an emulsifier that forms stable creams over the pH range 2.0 – 10.0
potentially provides advantages for pharmaceutical applications. As seen in Figure 22, increasing
amounts of 1.0-N NaOH gradually raises the creams pH to a value of 5.50. An inflection point
occurs between pH values 5.50 – 7.50, before returning to gradually increasing pH up to pH =
9.00. Regarding the pH values, the inflection point corresponds to the neutralization of the alkyl
phosphate surfactants (i.e., dicetyl phosphate and ceteth-10 phosphate) contained in the waxy
blend Crodafos CES. A pH value selected in the inflection point will make it difficult to target a
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specific cream pH value. The relatively small amounts of NaOH added could result in half unit
swings in the pH of the finished product.

Figure 22. The range between 3.50 and 9.00 is of most value to this formulation. Inflection point
pH range is 5.50 – 7.50. Representative error bars shown on select data points were determined
by replicate experiments.

Figure 23 compares the pH values of the separated water phase of the creams for both
ambient and accelerated (40°C) storage conditions at initial, 30-day, and 60-day. The data from
Figure 22 is tabulated in Table 6. No trends were identified for changes in the pH value upon
storage at either ambient or accelerated conditions. Some inherent variability in the pH values
can be seen in the data, but in general the before and after storage conditions agreed to within a
range of +/- 0.2, indicating chemical stability over a decent temperature range.
The mass of the aqueous phase obtained after centrifugation suggested a presence of a pH
dependence in the physical stability of the cream. For pH values below the inflection (pH < 6.00),
the emulsion is more difficult to break, as indicated by the decrease volume of the separated
aqueous phase. A decrease in aqueous phase mass after 2 months storage of creams across the pH
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profile is consistent with an increase in emulsion structure upon storage, at both ambient and
accelerated conditions. As the pH value of each cream increased across the profile the separated
aqueous phase mass increased, which indicated a less stable emulsion.

Figure 23. Plots A and B compare the mass of aqueous phase obtained after centrifugation under
ambient and accelerated conditions, respectively. Plots C and D compare the pH values of the
extracted aqueous phases under both ambient and accelerated conditions, respectively. Error bars
were determined for select samples by replication.

The instability in creams containing higher pH values corresponds to the increase
effective size of the hydrophilic head of the surfactant. The larger head group is caused by the
neutralization of phosphate groups by the Na+ ions increasing its effective size ratio (i.e., CPP)
compared to its hydrophobic tail. The increased ratio between the head and tail of the surfactant
decreases its attractive force to the O/W interface. This creates instability in the emulsion, which
is apparent in the increased mass of the removed aqueous phase as the increased volume of
NaOH. As mentioned above, the CPP ratio determines the spatial packing of the surfactant
molecules (e.g., lamellar LCs).
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Table 6. Tabulated data from Figure 23.
1.0-N
pH 30-day
NaOH
Initial pH
Ambient
added (g)
4.072
3.01
3.50

pH 30-day pH 60-day
(40°C)
Ambient

pH 60-day
(40°C)

3.46

3.43

3.53

6.002

3.58

3.84

3.86

3.76

3.87

10.12

4.80

4.74

4.92

4.66

4.73

11.06

5.13

5.05

5.23

5.10

5.02

12.08

5.89

5.62

5.77

5.80

5.62

13.05

7.58

7.37

7.43

7.43

7.23

14.04

7.85

7.93

7.97

7.99

7.82

15.02

8.19

8.26

8.30

8.27

8.10

16.03

8.46

8.50

8.57

8.58

8.38

17.06

8.68

8.71

8.76

8.60

8.60

18.03

8.84

9.35

8.86

8.79

8.80

22.03

9.45

10.10

9.45

9.40

9.43

B. PLM Micrograph
When a LC stabilized emulsion is viewed under PLM, the image will contain a pattern of
birefringence. The birefringence results from the unique structure of the LC in the emulsion
having a diversity of orientations. The PLM images in Figure 23 are shown for pH values 4.80,
5.89, and 8.19. The birefringence patterns found in the images show the Crodafos CES
emulsions are anisotropic creams at ambient conditions across the entire pH range. A
characteristic pattern for lamellar LLCs, also known as “Maltese Cross”, were observed for pH
values below pH 8.19 (Figure 24).
As NaOH is added to bring the pH to the inflection point (pH 5.89) the birefringent
material, while mostly remaining lamellar, become less abundant and more inhomogeneous.
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When a sufficient amount of NaOH solution has been added to the emulsion to bring the pH
value above the inflection point, the appearance of the birefringence material becomes even more
inhomogeneous and indicates a shift in stability (pH 8.10).
The abundance, and homogeneity of the lamellar structure is observed to have a pH
dependence. Below the inflection point the phosphate surfactant is in its acidic form, and here we
see an increase in birefringence and strong lamellar structure. Above the inflection point the
phosphate surfactant is in its base form. In the basic environment the lamellar structure is weak
and clustered together causing a decrease homogeneity of LCs in the emulsion. Inside the
inflection point the now neutralized ionic surfactant struggles in creating lamellar LLCs which is
apparent in the limited amount of birefringence seen under crossed polarization.

C. Thermal Study
An emulsion sample from below the inflection point, pH 4.80, was placed onto a lowprofile heating and cooling hot stage to observe the changes in the structure and presence of
LLCs in the emulsion. Images were taken as the emulsion was heated to 44.6°C and cooled to
24.8°C (Figure 25). This pH value was chosen due to the abundance of lamellar LLCs presence
in the emulsion.
The appearance and abundance of lamellar LLC’s decreased as the temperature slowly
increased. When the temperature reached to 44.6 °C some birefringence could still be seen, but
most of the image turned isotropic, and the characteristic Maltese cross features were no longer
observed. As the sample slowly cooled back toward room temperature the birefringence slowly
reappeared. Some Maltese cross features can be seen in the final cooled image (Image F).
However, they are not equivalent to those observed before heating (Image A). One important
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result from the thermal experiment is that although the lamellar LLC structure appears to
disappear at raised temperatures, the intensity of the birefringence is reversible upon cooling.
The reversibility of the intensity could indicate that a morphology did not occur, but rather the
alkyl alignment became more fluid which decreased its intensity. The characteristic structure was
difficult to locate as well. As the lamellar LLCs were heated then cooled it is possible the stacked
bilayers went from symmetric to asymmetric resulting in an altered birefringent observation.49
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Figure 24. Microscope images of three emulsions with varied pH values: pH 4.80 (column A),
pH 5.89 (column B), and pH 8.19 (column C). Images in row 1 are viewed under bright field
illumination. Magnification: row 1, 88x; row 2, 88x; row 3, 220x, row 4, 880x.
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Figure 25. Micrographs of an emulsion sample with a pH of 4.80. A) 220x mag. at ambient
conditions, B) 220x at 34.7°C, C) 220x at 44.6°C, D) 220x after cooling to 26.8°C, E) 880x at
26.2°C, and F) 880x cooled to 24.8C. Image E is 880x magnification of image D, and while
changing objective the temperature dropped from 26.8°C – 26.2°C.
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CHAPTER IV: CONCLUSION AND FUTURE PROSPECTS

The addition of the emulsifying wax blend (Crodafos CES) forms a lamellar lyotropic
liquid crystal stabilized oil-in-water emulsion over a wide pH range 3.50 to 9.00. This moisturizing
cream remains physically and chemically stable after two months of storage at (40°C) after
incorporation of 25 wt% of DEGEE, indicating a lasting shelf life. The presence of lamellar
lyotropic liquid crystals was found to be pH dependent, with their presence decreasing with
increasing cream pH. It may be desirable, for the proper production of lamellar LLCs, for the
formulator to formulate the emulsion in the phosphate surfactants acid form.
The broad range of pH tunability and presence of lamellar lyotropic liquid crystals provide
advantages in formulating creams containing ionizable APIs. As mentioned in the introduction,
active pharmaceutical ingredients would need to be non-ionized for diffusion across the skin
(stratum corneum); an ionized active pharmaceutical ingredient has a lower permeability
coefficient. Thus, controlling the ionization of an active pharmaceutical ingredient can be
completed utilizing this formulation.
The thermal study provided interesting results towards the intensity change in the
birefringence of lamellar lyotropic liquid crystals in the finished cream. During the thermal study,
the once anisotropic cream turned isotropic at elevated temperatures. As the cream cooled to
ambient conditions the anisotropic material reappeared, indicating reversibility, which may prove
no change in microstructure, but rather a change in alkyl alignment and shifting of the stacked
bilayers.
It would be of interest to utilize other instrumentation to truly determine if the isotropic
moment during the thermal study had any structural changes versus intensity reduction. Small-
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and wide-angle diffraction could be implemented as well as NMR. Applying the thermal study to
creams with other pH values may be helpful if a structural change in the crystal structure is a
possible outcome. Creams with pH values below 4.80 were not observed vigorously under crossed
polarization to determine the abundance and presence of lamellar LLCs. It would be of interest to
evaluate all pH values with intent to verify the existence of lamellar LLCs.
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